Stay updated on BBP-398 + Osimertinib in EGFR+ NSCLC: Clinical Trial

Sign up to get notified when there's something new on the BBP-398 + Osimertinib in EGFR+ NSCLC: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the BBP-398 + Osimertinib in EGFR+ NSCLC: Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, replacing the study details with an access-denied screen.
    Difference
    17%
    Check dated 2026-09-22T20:59:15.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision updated from v3.6.6 to v3.7.0, indicating a newer page version. This change appears to be a non-content update to the page's template or formatting rather than any study details.
    Difference
    0.1%
    Check dated 2026-09-15T20:56:24.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The page revision tag was updated to v3.6.6, replacing the previous v3.6.5 on the study record.
    Difference
    0.1%
    Check dated 2026-09-01T20:55:53.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.4 to v3.6.5, indicating a new version of the ClinicalTrials.gov page was published. This appears to be a minor update or correction rather than a change to the study data or eligibility criteria.
    Difference
    0.1%
    Check dated 2026-08-11T22:06:28.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.3 to v3.6.4. This indicates a minor page refresh or metadata update on the study details page without altering the study information.
    Difference
    0.1%
    Check dated 2026-07-21T12:50:55.000Z thumbnail image
  7. Check
    91 days ago
    Change Detected
    Summary
    The revision label on the page updated to v3.6.3, replacing the previous v3.6.0.
    Difference
    0.1%
    Check dated 2026-06-30T00:55:34.000Z thumbnail image

Stay in the know with updates to BBP-398 + Osimertinib in EGFR+ NSCLC: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the BBP-398 + Osimertinib in EGFR+ NSCLC: Clinical Trial page.